250 related articles for article (PubMed ID: 19027146)
1. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis.
Aletti GD; Podratz KC; Moriarty JP; Cliby WA; Long KH
Gynecol Oncol; 2009 Jan; 112(1):16-21. PubMed ID: 19027146
[TBL] [Abstract][Full Text] [Related]
2. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
Aletti GD; Dowdy SC; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2007 Dec; 197(6):676.e1-7. PubMed ID: 18060979
[TBL] [Abstract][Full Text] [Related]
3. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
4. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
5. Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis.
Greving JP; Vernooij F; Heintz AP; van der Graaf Y; Buskens E
Gynecol Oncol; 2009 Apr; 113(1):68-74. PubMed ID: 19176236
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.
Aletti GD; Dowdy SC; Podratz KC; Cliby WA
Gynecol Oncol; 2006 Feb; 100(2):283-7. PubMed ID: 16182350
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery.
Dainty L; Maxwell GL; Clarke-Pearson DL; Myers ER
Gynecol Oncol; 2004 May; 93(2):366-73. PubMed ID: 15099947
[TBL] [Abstract][Full Text] [Related]
9. Surgical care of young women diagnosed with ovarian cancer: a population-based perspective.
Tanner EJ; Zahurak ML; Bristow RE; Díaz-Montes TP
Gynecol Oncol; 2008 Nov; 111(2):221-5. PubMed ID: 18786718
[TBL] [Abstract][Full Text] [Related]
10. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope CR; Wilson TO; Podratz KC; Cliby WA
Obstet Gynecol; 2006 Jan; 107(1):77-85. PubMed ID: 16394043
[TBL] [Abstract][Full Text] [Related]
11. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
[TBL] [Abstract][Full Text] [Related]
12. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial.
North RB; Kidd D; Shipley J; Taylor RS
Neurosurgery; 2007 Aug; 61(2):361-8; discussion 368-9. PubMed ID: 17762749
[TBL] [Abstract][Full Text] [Related]
14. Quality of care in advanced ovarian cancer: the importance of provider specialty.
Mercado C; Zingmond D; Karlan BY; Sekaris E; Gross J; Maggard-Gibbons M; Tomlinson JS; Ko CY
Gynecol Oncol; 2010 Apr; 117(1):18-22. PubMed ID: 20106512
[TBL] [Abstract][Full Text] [Related]
15. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Chi DS; Eisenhauer EL; Zivanovic O; Sonoda Y; Abu-Rustum NR; Levine DA; Guile MW; Bristow RE; Aghajanian C; Barakat RR
Gynecol Oncol; 2009 Jul; 114(1):26-31. PubMed ID: 19395008
[TBL] [Abstract][Full Text] [Related]
16. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
18. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
[TBL] [Abstract][Full Text] [Related]
19. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience.
Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope RC; Wilson TO; Podratz KC; Cliby WA
J Am Coll Surg; 2009 Apr; 208(4):614-20. PubMed ID: 19476798
[TBL] [Abstract][Full Text] [Related]
20. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]